• Educational resources
  • Events
  • Expert Panel
No matches
  • Cookie policy
  • Privacy policy
  • About us
  • Join ADVENT

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2026 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-US-2305040 v4.0 – P Expiration Date: 10/16/2027

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region

Educational Resources

Categories
Dermatology: 
  • Atopic dermatitis
  • Bullous pemphigoid
  • Chronic pruritus of unknown origin
  • Chronic spontaneous urticaria
  • Prurigo nodularis
Gastroenterology: 
  • Eosinophilic esophagitis
Pulmonology: 
  • Asthma
  • Chronic obstructive pulmonary disease
  • IL-33
Rhinology: 
  • Chronic rhinosinusitis with nasal polyps
Filters
Topic: 
  • Burden of disease
  • Pathophysiology
  • Guidelines and recommendations
  • Clinical management
  • Co-existing type 2 inflammatory diseases
Format: 
  • Expert Video
  • Podcast
  • Slide presentation
  • Infographic
  • Video animation
  • Interactivity
Length: 
  • Short (<5 minutes)
  • Medium (5-15 minutes)
  • Long (> 15 minutes)
Sort by: Newest
  • Newest
  • Oldest
  • A-Z
  • Z-A
Understanding Disease Mechanisms
Dermatology
5 min
expert video

Understanding Disease Mechanisms

Stepping Into Hand and Foot Dermatitis
Dermatology
14 min
expert video

Stepping Into Hand and Foot Dermatitis

ADVENT On Air - Dermatology
Dermatology
45 min
Podcast

ADVENT On Air | Expert Discussions in Dermatology

UEGW 2024 | WHY Is Long-Term Management of EoE Important?
Gastroenterology
10 min
expert video

UEGW 2024 | WHY Is Long-Term Management of EoE Important?

ERS 2024 | Airway Remodeling: A Permanent or Transitory Consequence in Severe Asthma Patients?
Pulmonology
78 min
expert video

ERS 2024 | Airway Remodeling: A Permanent or Transitory Consequence in Severe Asthma Patients?

Pathophysiology of Blister Formation in Bullous Pemphigoid
Dermatology
2 min
expert video

Pathophysiology of Blister Formation in Bullous Pemphigoid

Prurigo Nodularis Myths and Facts
Dermatology
13 min
expert video

Prurigo Nodularis Myths and Facts

Role of Type 2 Inflammation in Prurigo Nodularis Part 2: Itch and Skin Lesions
Dermatology
13 min
expert video

Role of Type 2 Inflammation in Prurigo Nodularis Part 2: Itch and Skin Lesions

Role of Type 2 Inflammation in Prurigo Nodularis         Part 1: Overview of Type 2 Inflammation
Dermatology
8 min
expert video

Role of Type 2 Inflammation in Prurigo Nodularis Part 1: Overview of Type 2 Inflammation

Overview of Prurigo Nodularis Part 2: Burden of Disease and Considerations of Patient Care
Dermatology
5 min
expert video

Overview of Prurigo Nodularis Part 2: Burden of Disease and Considerations of Patient Care

Overview of Prurigo Nodularis Part 1: Clinical Features, Epidemiology, and Diagnosis
Dermatology
9 min
expert video

Overview of Prurigo Nodularis Part 1: Clinical Features, Epidemiology, and Diagnosis

Mechanisms of Disease: Autoimmunity and Role of Type 2 Inflammation in BP
Dermatology
15 min
expert video

Mechanisms of Disease: Autoimmunity and Role of Type 2 Inflammation in Bullous Pemphigoid (BP)

    1
    ...
    131415
    ...
    24